It seems we can’t find what you’re looking for. Perhaps searching can help.
- 3415
[] Institution:Study Staff Contact – [3415] Trial:A Double-Blind Placebo-Controlled Randomized Phase III Trial of Fulvestrant and Ipatasertib as Treatment for Advanced HER-2 Negative and Estrogen Receptor Positive (ER+) Breast Cancer Following Progression on First Line CDK 4/6 Inhibitor and Aromatase Inhibitor (FINER)